The menopausal transition involves profound shifts in oestrogen and progesterone levels, triggering vasomotor symptoms such as hot flushes and night sweats, alongside mood changes, sleep disruption, and vaginal dryness.
The menopausal transition involves profound shifts in oestrogen and progesterone levels, triggering vasomotor symptoms such as hot flushes and night sweats, alongside mood changes, sleep disruption, and vaginal dryness. Whilst conventional hormone replacement therapy addresses many symptoms, some women seek or require alternatives. Regenerative medicine approaches—particularly placental-derived exosomes and mesenchymal stem cells—are being studied as potential supplements to traditional management, with interest centred on whether these agents might support natural hormonal regulation and tissue repair. Current research remains exploratory, focused on mechanisms rather than clinical equivalence to established treatments.
| Cost indicativ · Bulgaria (UE) | €3,000–€8,000 |
|---|---|
| Gama costurilor pieței globale | €6,440–€23,000 (placidway.com) |
| Principalele tipuri de celule studiate | Exosomes, Placenta Extract, MSCs from Amniotic Membrane |
| Statutul aprobării | Investigațional |
| Studii înregistrate (ClinicalTrials.gov) | 10 |
For the clinic's own description, see our partner clinic Stem Plus.
Approximately 10 registered trials are investigating stem cell and exosome therapies for menopause-related symptoms. A 2023 small-scale study of placental MSCs reported subjective improvement in hot flush frequency in 70% of participants over 12 weeks, though follow-up assessments remain limited. Exosome trials have focused on anti-inflammatory signalling rather than direct hormone replacement. No large multicentre randomised controlled trials have yet demonstrated safety or efficacy comparable to hormone therapy, and recruitment for new menopause-focused stem cell studies has stalled. Evidence remains preliminary and largely mechanistic.
Depending on assessment, a Menopause & Hormonal Health protocol may draw on:
Regenerative treatments for menopausal symptoms typically range from £3,000 to £8,000 per course abroad, with some clinics offering packages combining exosomes and MSCs. UK private clinics offering stem cell-adjacent treatments charge upwards of £2,500 for initial consultations and injections. Importantly, these interventions sit outside standard NHS coverage and are not regulated under established pharmaceutical frameworks. Costs reflect research and manufacturing rather than proven clinical advantage over hormone therapy, which may cost £30–£100 annually via prescription.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Menopause & Hormonal Health cost-by-country breakdown, or compare the best countries for Menopause & Hormonal Health →
Before booking, check safety & regulation, the recovery climate, dacă ai putea fi candidat, and which cell type fits Menopause & Hormonal Health.
FAQ complet Menopauza și Sănătatea Hormonală → · Defalcare costuri Menopauza și Sănătatea Hormonală →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: Sunt eu un candidat? · Ce tip de celulă? · Types of clinics & best countries · Calculator de costuri
Revizuit medical de echipa editorială a StemCellAtlas cu Dr Dmytro Stoyanov (Urologist · 31+ yrs clinical practice) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită